Carolina Martinez-Ciarpaglini

Carolina Martinez-Ciarpaglini

Auto-generated profile, based on publicly available information

Carolina Martinez-Ciarpaglini

Department of Pathology. Hospital Clínico Universitario of Valencia. Biomedical Research Institute INCLIVA, University of Valencia, Spain

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2025 in International Journal of Colorectal Disease
Verified
Journal Article
Open access
PDF file
DMDavid Moro-Valdezate
David Moro-Valdezate
JMJOSE MARTIN-AREVALO
JOSE MARTIN-AREVALO
CCCoral Cózar-Lozano
Coral Cózar-Lozano
SGStephanie García-Botello
Stephanie García-Botello
LPLeticia Pérez-Santiago
Leticia Pérez-Santiago
VPVicente Pla-Martí
Vicente Pla-Martí
Purpose: This study aimed to develop a prognostic model for colorectal cancer (CRC) patients using biomarkers from routine preoperative peripheral blood examinations combined with clinical factors. Methods: This observational study comprised CRC patients (stages I–III) who underwent curative surgery between January 2011 and December 2019. Study variables included patient demographics, tumour characteristics, and immune/inflammatory markers from preoperative blood tests. Cut-off thresholds for continuous variables were determined using maximally selected rank statistics. Univariate and multivariate analyses identified variables associated with 3-year cancer-specific survival (CSS) and disease-free survival (DFS). Cox regression models were developed and validated using a random split-sample approach. Nomograms based on these models were constructed, and receiver operating characteristic (ROC) curves were generated for 12, 24 and 36 months. Results: A total of 764 patients were included. Independent factors for 3-year DFS included laparoscopic surgery, prognostic nutritional index (PNI), neutrophil count, lymphocyte count, and Charlson comorbidity index. The DFS prediction model showed AUC values of 66.6%, 64.8%, and 69% for years 1, 2, and 3, respectively. For CSS, independent factors included age, systemic immune-inflammation index (SII), serum albumin, and platelet count, with AUC values of 89.2%, 76.8%, and 71% for years 1, 2, and 3. The most significant contributors to the CSS model were SII and platelet cut-off values. Conclusion: Inflammatory biomarkers combined with clinical parameters robustly predict 3-year survival outcomes in CRC patients undergoing curative resection. These findings highlight the importance of systemic inflammation in CRC prognosis and support its inclusion in preoperative risk stratification.

16 March 2025 in Pathology - Research and Practice
Verified
Journal Article
Closed access
BLBrenda Palomar de Lucas
Brenda Palomar de Lucas
BHBegoña Heras
Begoña Heras
NTNoelia Tarazona
Noelia Tarazona
MOMaría Ortega
María Ortega
MHMarisol Huerta
Marisol Huerta
CMCarolina Martinez-Ciarpaglini
Carolina Martinez-Ciarpaglini